コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dules, rheumatoid factor seropositivity, and erythrocyte sedimentation rate).
2 se reactants, such as C-reactive protein and erythrocyte sedimentation rate.
3 joints with limited range of motion; and 6) erythrocyte sedimentation rate.
4 odified Health Assessment Questionnaire, and erythrocyte sedimentation rate.
5 arrhea, fever, weight loss, and an increased erythrocyte sedimentation rate.
6 perlipidemia is indicated by their increased erythrocyte sedimentation rate.
7 e protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.
8 th the presence of nephritis and an elevated erythrocyte sedimentation rate.
9 elated, in part, to smoking and an increased erythrocyte sedimentation rate.
10 ed by disease duration, 5% by the Westergren erythrocyte sedimentation rate, 14% by articular signs a
11 nt 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation rate 25.1 mm/hour) despite tre
12 ures [3 patient and 3 assessor measures plus erythrocyte sedimentation rate]); 3) patient-only (media
13 ints, Larsen radiographic score 20 versus 3, erythrocyte sedimentation rate 33 mm/hour versus 20, and
14 6 months (mean tender joint count 28.2, mean erythrocyte sedimentation rate 46.5 mm/hour) were random
15 ne kinase, thyroid-stimulating hormones, and erythrocyte sedimentation rate; all analyses were perfor
19 ned the relation between leukocyte count and erythrocyte sedimentation rate and diabetes incidence us
20 related with biomarkers of disease activity (erythrocyte sedimentation rate and double-stranded DNA c
21 serum albumin; MR was associated with higher erythrocyte sedimentation rate and lower albumin at all
23 cular dysfunction was associated with higher erythrocyte sedimentation rate and, at diagnosis only, l
25 articipants, the use of drugs was noted, and erythrocyte sedimentation rates and serum levels of high
26 acute-phase reactants (C-reactive protein), erythrocyte sedimentation rate, and bone metabolism mark
27 ng hormone level, autoimmune antibody level, erythrocyte sedimentation rate, and C-reactive protein l
28 me) and disease activity (total joint count, erythrocyte sedimentation rate, and C-reactive protein)
29 uality of life, enthesitis, chest expansion, erythrocyte sedimentation rate, and C-reactive protein,
31 plained, statistically, by pain, depression, erythrocyte sedimentation rate, and disease duration.
32 mation markers C-reactive protein (CRP), the erythrocyte sedimentation rate, and interleukin-6 (IL-6)
34 ated with a reduction in C-reactive protein, erythrocyte sedimentation rate, and pericardial LGE in t
35 ectively), and lower white blood cell count, erythrocyte sedimentation rate, and platelet count (all
36 l sites, lactate dehydrogenase (LDH) levels, erythrocyte sedimentation rate, and platelet count did n
38 gher anti-double-stranded DNA (dsDNA) titer, erythrocyte sedimentation rate, and SLE Disease Activity
39 seline and week 4 in the tender joint count, erythrocyte sedimentation rate, and urinary excretion of
40 d significantly increased neutrophil counts, erythrocyte sedimentation rates, and C-reactive protein,
41 mplete blood cell counts, metabolic factors, erythrocyte sedimentation rates, and levels of C-reactiv
43 demonstrated that a model which included the erythrocyte sedimentation rate at baseline (P = 0.005) a
44 k factors (ie, age, clinical stage, elevated erythrocyte sedimentation rate, B symptoms, large medias
45 ients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.
46 ), joint swelling, joint pain or tenderness, erythrocyte sedimentation rate, C-reactive protein level
47 f the type of uveitis (complete blood count, erythrocyte sedimentation rate, C-reactive protein, tube
49 eumatologist ranked ACR 20, radiography, and erythrocyte sedimentation rate/c-reactive protein as the
51 eline levels of C-reactive protein and lower erythrocyte sedimentation rates compared with patients d
53 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
54 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
55 ivity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less th
56 isease Activity Score in 28 joints using the erythrocyte sedimentation rate (DAS28-ESR) was >/=3.2.
57 ctivity (disease activity score in 28 joints-erythrocyte sedimentation rate [DAS28-ESR] >/= 3.2 [rang
58 [LDA] according to Disease Activity Score 28-erythrocyte sedimentation rate [DAS28-ESR] </=3.2 or DAS
62 f 5.29 mg to 0.34 mg per deciliter), and the erythrocyte sedimentation rate decreased at month 3 (all
64 osteomyelitis may have an increase in their erythrocyte sedimentation rate during the first 2 weeks
65 (anemia, thrombocytopenia leukocytosis, high erythrocyte sedimentation rate, elevated levels of C-rea
66 ips, or proximal aspects of the thighs), and erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
67 ck, shoulders, or hip girdle regions; and an erythrocyte sedimentation rate (ESR) > or = 40 mm/hour.
68 e age <65 years (OR = 10.647, P = 0.023) and erythrocyte sedimentation rate (ESR) >30 (OR = 6.414, P
69 variate analysis, age younger than 60 years, erythrocyte sedimentation rate (ESR) 20 mm/h or less, an
72 There is a positive correlation between the erythrocyte sedimentation rate (ESR) and large bowel upt
73 ents were assessed for correlations with the erythrocyte sedimentation rate (ESR) and platelet count.
74 riate analysis for EFS are stage of disease, erythrocyte sedimentation rate (ESR) at diagnosis, liver
75 of the respondents reported using either the erythrocyte sedimentation rate (ESR) or C-reactive prote
76 ), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at ba
77 th, the Health Assessment Questionnaire, and erythrocyte sedimentation rate (ESR) were used to develo
78 nderness, 3) physician global assessment, 4) erythrocyte sedimentation rate (ESR), 5) functional disa
81 s were calculated to estimate effect of age, erythrocyte sedimentation rate (ESR), and C-reactive pro
82 effect of acupuncture on morning stiffness, erythrocyte sedimentation rate (ESR), and C-reactive pro
83 a, hematuria, low hemoglobin level, elevated erythrocyte sedimentation rate (ESR), and presence of an
85 nd rheumatoid factor-negative polyarthritis, erythrocyte sedimentation rate (ESR), C-reactive protein
86 fasting insulin, glucose, and lipid levels, erythrocyte sedimentation rate (ESR), C-reactive protein
87 ere obtained periodically for measurement of erythrocyte sedimentation rate (ESR), C-reactive protein
88 at every visit included determination of the erythrocyte sedimentation rate (ESR), grip strength, pai
89 lesterol, triglycerides, C-reactive protein, erythrocyte sedimentation rate (ESR), hemoglobin, total
92 rythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation
97 tor (RF) positivity (93% versus 84%), higher erythrocyte sedimentation rate (ESR; 45 versus 36 mm/hr)
98 correlated with untreated disease activity (erythrocyte sedimentation rate [ESR]) (r = 0.5, P = 0.00
99 hysician's and patient's global assessments, erythrocyte sedimentation rate [ESR], and morning stiffn
100 atory markers (white blood cell [WBC] count, erythrocyte sedimentation rate [ESR], C-reactive protein
101 enderness, swelling, and deformity, nodules, erythrocyte sedimentation rate [ESR], C-reactive protein
102 onnaire), and serum markers of inflammation (erythrocyte sedimentation rate [ESR], high-sensitivity C
103 rity (rheumatoid factor [RF] seropositivity, erythrocyte sedimentation rate [ESR], joint swelling, ra
104 tional diagnostic tests include blood tests (erythrocyte sedimentation rate, ESR; C-reactive protein,
106 ious infection, corticosteroid use, elevated erythrocyte sedimentation rate, extraarticular manifesta
107 ps with regard to abnormal elevations of the erythrocyte sedimentation rate following initial remissi
108 of amyloid A and C-reactive protein, and the erythrocyte sedimentation rate from baseline to month 3
110 ture >38.8 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
111 ture >38.3 degrees C, leukorrhea or mucopus, erythrocyte sedimentation rate >15 mm/hour, white blood
112 ions (P = 0.01), myositis (P = 0.02), and an erythrocyte sedimentation rate >40 mm/hour (P < 0.001) w
114 naire Disability Scale, global severity, and erythrocyte sedimentation rate had a 3-6 times increased
116 joint counts, C-reactive protein levels, and erythrocyte sedimentation rates had fallen significantly
118 on, and basic blood tests, which include the erythrocyte sedimentation rate, hemoglobin, white count,
119 greater physical function limitation, higher erythrocyte sedimentation rate, higher joint count sever
120 CI) 0.03-0.35, P < 0.0005]), as was a higher erythrocyte sedimentation rate (HR 0.80 [95% CI 0.67-0.9
121 ngoing inflammation as indicated by elevated erythrocyte sedimentation rate, hypocomplementemia, and/
124 those for the C-reactive protein levels and erythrocyte sedimentation rates in the same patients.
125 evated peripheral white blood cell count and erythrocyte sedimentation rate may herald an infection o
126 of tocilizumab, the C-reactive protein level/erythrocyte sedimentation rate normalized, while placebo
127 erythrocytes may contribute to the elevated erythrocyte sedimentation rates observed in inflammatory
128 usted hazard ratios for participants with an erythrocyte sedimentation rate of > or = 26 mm/hour comp
129 6 mm/hour compared with participants with an erythrocyte sedimentation rate of < or = 5 mm/hour were
130 f 8.5 IU/mL (normal range, 0-13.9 IU/mL), an erythrocyte sedimentation rate of 2 mm/hr (normal range,
131 ormal value, <10 mg/L [95.2 nmol/L]), and an erythrocyte sedimentation rate of 35 mm per hour (normal
132 el of less than 5 mg/L (47.6 nmol/L), and an erythrocyte sedimentation rate of 41 mm/h (0-15 mm/h).
134 cts were noted in individual ACR components, erythrocyte sedimentation rate, onset of ACR20 response,
135 th the inflammatory variant have an elevated erythrocyte sedimentation rate or abnormalities of other
136 , even without immediate availability of the erythrocyte sedimentation rate or the C-reactive protein
137 smoking (OR 1.02, P = 0.04) and an elevated erythrocyte sedimentation rate (OR 1.02, P = 0.05) were
138 phocytosis (OR, 1.84; P = 0.0002), increased erythrocyte sedimentation rate (OR, 6.5; P = 0.0005), de
139 .039), low serum C4 (P = 0.046), an elevated erythrocyte sedimentation rate (P = 0.006), and abnormal
140 -glycoprotein concentration (p = 0.012), and erythrocyte sedimentation rate (p = 0.01); concentration
141 creases in albumin (P<.001) and decreases in erythrocyte sedimentation rate (P<.05), interleukin-6 (P
142 ated patients had greater mean reductions in erythrocyte sedimentation rate (p=0.009) and a two-fold
143 italization (P=0.05) and, at week 1, a lower erythrocyte sedimentation rate (P=0.02) and a tendency t
144 nts who experienced complications had higher erythrocyte sedimentation rates (P<0.001) and C-reactive
145 ficant improvement in 3 of 5 core variables (erythrocyte sedimentation rate, physician's global asses
146 4) levels were significantly reduced, as was erythrocyte sedimentation rate, possibly as a result of
147 orrelated with the C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor level,
148 disease duration, C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, nodul
149 o had higher baseline C-reactive protein and erythrocyte sedimentation rate than the persistent CP gr
150 interval 1.18-12.59], P=0.026) alongside the erythrocyte sedimentation rate, triglyceride level, pred
152 he most frequent presenting symptom, and the erythrocyte sedimentation rate was elevated in 98% of ca
154 lower physical QOL during followup, whereas erythrocyte sedimentation rate was most strongly associa
155 and C-reactive protein (CRP), as well as the erythrocyte sedimentation rate were measured serially.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。